Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Longitudinal Response Trajectories with Dupilumab or Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Multicentre Real-World Study: IL-AD (Italian Landscape Atopic Dermatitis)

Saved in:
Bibliographic Details
Published in:Dermatology and Therapy
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867301678385987585
collection WordPress RSS
FRELIP Feed Integration
container_title Dermatology and Therapy
description
discipline_display Dermatology and Venereology
discipline_facet Dermatology and Venereology
format Online Article
RSS Article
genre Journal Article
id rss_article:76700
institution FRELIP
journal_source_facet Dermatology and Therapy
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Longitudinal Response Trajectories with Dupilumab or Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Multicentre Real-World Study: IL-AD (Italian Landscape Atopic Dermatitis)
Dermatology and Venereology
General
Dermatology and Venereology
sub_discipline_display General
sub_discipline_facet General
subject_display Dermatology and Venereology
General
Dermatology and Venereology
Dermatology and Venereology
General
Dermatology and Venereology
subject_facet Dermatology and Venereology
General
Dermatology and Venereology
title Longitudinal Response Trajectories with Dupilumab or Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Multicentre Real-World Study: IL-AD (Italian Landscape Atopic Dermatitis)
title_auth Longitudinal Response Trajectories with Dupilumab or Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Multicentre Real-World Study: IL-AD (Italian Landscape Atopic Dermatitis)
title_full Longitudinal Response Trajectories with Dupilumab or Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Multicentre Real-World Study: IL-AD (Italian Landscape Atopic Dermatitis)
title_fullStr Longitudinal Response Trajectories with Dupilumab or Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Multicentre Real-World Study: IL-AD (Italian Landscape Atopic Dermatitis)
title_full_unstemmed Longitudinal Response Trajectories with Dupilumab or Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Multicentre Real-World Study: IL-AD (Italian Landscape Atopic Dermatitis)
title_short Longitudinal Response Trajectories with Dupilumab or Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Multicentre Real-World Study: IL-AD (Italian Landscape Atopic Dermatitis)
title_sort longitudinal response trajectories with dupilumab or upadacitinib in moderate-to-severe atopic dermatitis: a multicentre real-world study: il-ad (italian landscape atopic dermatitis)
topic Dermatology and Venereology
General
Dermatology and Venereology
url https://link.springer.com/article/10.1007/s13555-026-01781-3